Omeros | OMER - 当期純利益





当期純利益 変化する 日付
Adma Biologics USD 45.33M 4.05M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Cytokinetics USD -198.76M 7.27M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -13.24M 150.32M 2026-06
Knight Therapeutics CAD -3.79M 8.83M 2025-09
MacroGenics USD -36.77M 22.62M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 4.65M 1.74M 2026-06
Pfizer USD -248M 2.94B 2026-06
Rockwell Medical USD 343K 2.07M 2024-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
United Therapeutics USD 333M 58.1M 2026-06
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06